Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Inflammation cannabidiol:

Search results

Items: 1 to 20 of 152

1.

Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma.

Vuolo F, Abreu SC, Michels M, Xisto DG, Blanco NG, Hallak JE, Zuardi AW, Crippa JA, Reis C, Bahl M, Pizzichinni E, Maurici R, Pizzichinni MMM, Rocco PRM, Dal-Pizzol F.

Eur J Pharmacol. 2018 Nov 24;843:251-259. doi: 10.1016/j.ejphar.2018.11.029. [Epub ahead of print]

PMID:
30481497
2.

Impact of recreational and medicinal marijuana on surgical patients: A review.

Bakshi C, Barrett AM.

Am J Surg. 2018 Nov 14. pii: S0002-9610(18)31123-1. doi: 10.1016/j.amjsurg.2018.10.053. [Epub ahead of print] Review.

PMID:
30471810
3.

Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats.

Santiago AN, Mori MA, Guimarães FS, Milani H, Weffort de Oliveira RM.

Neurotox Res. 2018 Nov 14. doi: 10.1007/s12640-018-9972-5. [Epub ahead of print]

PMID:
30430393
4.

Cannabis for the treatment of Crohn's disease.

Kafil TS, Nguyen TM, MacDonald JK, Chande N.

Cochrane Database Syst Rev. 2018 Nov 8;11:CD012853. doi: 10.1002/14651858.CD012853.pub2. Review.

PMID:
30407616
5.

Cannabinoid Delivery Systems for Pain and Inflammation Treatment.

Bruni N, Della Pepa C, Oliaro-Bosso S, Pessione E, Gastaldi D, Dosio F.

Molecules. 2018 Sep 27;23(10). pii: E2478. doi: 10.3390/molecules23102478. Review.

PMID:
30262735
Free PMC Article
6.

Ca2+ Signaling and IL-8 Secretion in Human Testicular Peritubular Cells Involve the Cation Channel TRPV2.

Eubler K, Herrmann C, Tiefenbacher A, Köhn FM, Schwarzer JU, Kunz L, Mayerhofer A.

Int J Mol Sci. 2018 Sep 19;19(9). pii: E2829. doi: 10.3390/ijms19092829.

7.

Effect of cannabidiolic acid and ∆9-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain.

Rock EM, Limebeer CL, Parker LA.

Psychopharmacology (Berl). 2018 Nov;235(11):3259-3271. doi: 10.1007/s00213-018-5034-1. Epub 2018 Sep 17.

PMID:
30225659
8.

Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer.

Kosgodage US, Mould R, Henley AB, Nunn AV, Guy GW, Thomas EL, Inal JM, Bell JD, Lange S.

Front Pharmacol. 2018 Aug 13;9:889. doi: 10.3389/fphar.2018.00889. eCollection 2018.

9.

Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.

Elliott DM, Singh N, Nagarkatti M, Nagarkatti PS.

Front Immunol. 2018 Aug 3;9:1782. doi: 10.3389/fimmu.2018.01782. eCollection 2018.

10.

EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis.

García-Martín A, Garrido-Rodríguez M, Navarrete C, Del Río C, Bellido ML, Appendino G, Calzado MA, Muñoz E.

Biochem Pharmacol. 2018 Nov;157:304-313. doi: 10.1016/j.bcp.2018.07.047. Epub 2018 Aug 2.

PMID:
30076848
11.

Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice.

Iannotti FA, Pagano E, Moriello AS, Alvino FG, Sorrentino NC, D'Orsi L, Gazzerro E, Capasso R, De Leonibus E, De Petrocellis L, Di Marzo V.

Br J Pharmacol. 2018 Aug 3. doi: 10.1111/bph.14460. [Epub ahead of print]

PMID:
30074247
12.

Cannabidiol restores differentiation capacity of LPS exposed adipose tissue mesenchymal stromal cells.

Ruhl T, Kim BS, Beier JP.

Exp Cell Res. 2018 Sep 15;370(2):653-662. doi: 10.1016/j.yexcr.2018.07.030. Epub 2018 Jul 20.

PMID:
30036540
13.

VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways.

Del Rio C, Cantarero I, Palomares B, Gómez-Cañas M, Fernández-Ruiz J, Pavicic C, García-Martín A, Luz Bellido M, Ortega-Castro R, Pérez-Sánchez C, López-Pedrera C, Appendino G, Calzado MA, Muñoz E.

Br J Pharmacol. 2018 Oct;175(19):3813-3831. doi: 10.1111/bph.14450. Epub 2018 Aug 23.

PMID:
30033591
14.

The importance of 15-lipoxygenase inhibitors in cancer treatment.

Orafaie A, Matin MM, Sadeghian H.

Cancer Metastasis Rev. 2018 Jun 7. doi: 10.1007/s10555-018-9738-9. [Epub ahead of print]

PMID:
29882120
15.

The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice.

Li H, Kong W, Chambers CR, Yu D, Ganea D, Tuma RF, Ward SJ.

Cell Immunol. 2018 Jul;329:1-9. doi: 10.1016/j.cellimm.2018.02.016. Epub 2018 Mar 8.

PMID:
29784129
16.

Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis.

Petrosino S, Verde R, Vaia M, Allarà M, Iuvone T, Di Marzo V.

J Pharmacol Exp Ther. 2018 Jun;365(3):652-663. doi: 10.1124/jpet.117.244368. Epub 2018 Apr 9.

PMID:
29632236
17.

Cannabidiol to Improve Mobility in People with Multiple Sclerosis.

Rudroff T, Sosnoff J.

Front Neurol. 2018 Mar 22;9:183. doi: 10.3389/fneur.2018.00183. eCollection 2018. No abstract available.

18.

The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis.

Couch DG, Maudslay H, Doleman B, Lund JN, O'Sullivan SE.

Inflamm Bowel Dis. 2018 Mar 19;24(4):680-697. doi: 10.1093/ibd/izy014.

PMID:
29562280
19.

Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model.

Callejas GH, Figueira RL, Gonçalves FLL, Volpe FAP, Zuardi AW, Crippa JA, Hallak JE, Sbragia L.

Braz J Med Biol Res. 2018 Mar 15;51(5):e7132. doi: 10.1590/1414-431X20177132.

20.

The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation.

Thapa D, Cairns EA, Szczesniak AM, Toguri JT, Caldwell MD, Kelly MEM.

Cannabis Cannabinoid Res. 2018 Feb 1;3(1):11-20. doi: 10.1089/can.2017.0041. eCollection 2018.

Supplemental Content

Loading ...
Support Center